BofA Maintains Buy Rating on Marvell with $365 Target Price Implying 55% Upside
nashnova research
Bank of America reiterated a Buy rating and $365 price target on Marvell Technology, implying roughly 55% upside from its $236.10 close; the bull case rests on two growth curves — AI companion chips and data-center optical interconnects — but customer-project uncertainty and competitive pressure are the core risks.
Why is BofA so bullish on Marvell?
Analyst Vivek Arya published the report after meeting Marvell CEO Matt Murphy and CFO Dan Durn, maintaining a Buy rating and a $365 price target.
The bull thesis hinges on two growth curves: custom AI accelerator companion chips + data-center optical interconnect chips.
This means → BofA sees Marvell not as a single-product story but as a company positioned at two high-growth entry points in the AI compute buildout.
Where does the companion-chip revenue come from?
Each custom AI processor requires 1–2 companion chips priced at $500–$1,500 apiece — PCIe retimers (small chips that relay signals), CXL controllers (interfaces that let different chips share memory), high-speed optical interconnect chips, and co-packaged optics components.
BofA estimates the companion-chip market alone could exceed $60–65 billion by 2030; at a 40–50% share, Marvell's annual sales opportunity is roughly $30 billion.
Management's own 2028 outlook is $3–4 billion-plus; the custom-processor business adds another $15 billion, for a combined opportunity of $40–45 billion.
In plain terms = these figures are scenario math — "how big it could get if everything goes right" — not confirmed orders. The report itself makes that caveat explicit.
Why is optical interconnect the second engine?
Effective AI cluster compute increasingly depends on cross-node communication efficiency; as speeds and distances rise, copper links hit loss and power walls, pushing more connections toward optical.
Marvell's shipping Ara platform and expanded 1.6T product portfolio are the concrete products catching this upgrade wave.
Supply-chain corroboration: optical-component maker Lumentum expects related device shipments to roughly double from 2026 to 2027, with EML and CW laser shortages — the core light-emitting components inside optical modules — persisting through 2027.
This reflects a trend broader than Marvell alone: the entire supply chain is expanding capacity for this demand wave.
How does the $365 target break down?
Arya projects Marvell's CY2028 EPS near $14, above the $11 baseline; every additional $1 billion in revenue adds $0.30–0.35 per share.
The target uses 33× SBC-adjusted baseline earnings.
This means → 33× is already below Marvell's five-year average non-GAAP P/E of 42× — BofA applied a "discounted" multiple, yet it still sits above the 26× historical median.
Across Wall Street, 45 S&P Global analysts rate Marvell a Strong Buy with an average one-year target of $284.64 (≈20.6% upside); the street-high $400 comes from KeyBanc analyst John Vinh. BofA's $365 sits well above the consensus.
What are the risks?
Customer-project uncertainty: Amazon's and Microsoft's next-gen chip programs carry execution risk; delays would push revenue out.
Intense competition: Broadcom is the strongest incumbent in AI ASICs; Nvidia and AMD's standardized AI accelerators compete for the same spending pool.
Equity dilution: Marvell's partnership with Google includes purchase-linked warrants that could issue nearly 59 million shares.
Elevated valuation: a 33× target multiple exceeds the 26× historical median; any growth slowdown could hit both earnings estimates and the multiple — a double compression.
What should investors watch next?
October 6 Analyst Day is the near-term verification event.
The market needs concrete evidence on delivery timelines, margin expectations, and customer-program ramp progress — not bigger TAM projections.
In plain terms = the story is big enough on paper; now Marvell has to show the schedule and the orders to back it up.
市场有风险，内容仅供研究参考，不构成投资建议。